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Abstract
ZFYVE27 (Protrudin) was originally identified as an interacting partner of spastin, which is most frequently mutated in
hereditary spastic paraplegia. ZFYVE27 is a novel member of FYVE family, which is implicated in the formation of neurite
extensions by promoting directional membrane trafficking in neurons. Now, through a yeast two-hybrid screen, we have
identified that ZFYVE27 interacts with itself and the core interaction region resides within the third hydrophobic region
(HR3) of the protein. We confirmed the ZFYVE27’s self-interaction in the mammalian cells by co-immunoprecipitation and
co-localization studies. To decipher the oligomeric nature of ZFYVE27, we performed sucrose gradient centrifugation and
showed that ZFYVE27 oligomerizes into dimer/tetramer forms. Sub-cellular fractionation and Triton X-114 membrane phase
separation analysis indicated that ZFYVE27 is a peripheral membrane protein. Furthermore, ZFYVE27 also binds to
phosphatidylinositol 3-phosphate lipid moiety. Interestingly, cells expressing ZFYVE27
DHR3 failed to produce protrusions
instead caused swelling of cell soma. When ZFYVE27
DHR3 was co-expressed with wild-type ZFYVE27 (ZFYVE27
WT), it exerted
a dominant negative effect on ZFYVE27
WT as the cells co-expressing both proteins were also unable to induce protrusions
and showed cytoplasmic swelling. Altogether, it is evident that a functionally active form of oligomer is crucial for ZFYVE27
ability to promote neurite extensions.
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Introduction
The sprouting of neurite extension is a critical event in
neuritogenesis, which serve as precursor for both axon and
dendrites of the neuron. The budding and elongation of neurites in
the developing neurons at the precise time and in the right
direction is decisive for proper neuronal differentiation and
connectivity [1]. Furthermore, in neurodegenerative disorders,
changes in the pattern of neurite outgrowth have been observed.
For the neurites to spike out from the cell soma or the parent axon;
coordinated and widespread regulation of the cytoskeleton and
membrane trafficking machinery are crucial [1,2]. In terms of
cytoskeleton remodeling, particularly, the long and stable
microtubules (MT) of the parent axon must be locally severed
into short highly mobile pieces that are able to shift into the newly
forming branch sites to promote neurite outgrowth [3,4].
In a recent study, it was shown that overexpression of spastin in
neurons results in a dramatic increase in the neurite outgrowth
(axonal branch formation) from the main axon [5]. Spastin is a
MT severing enzyme, which belongs to AAA (ATPase Associated
with various cellular Activities) family of proteins. Spastin shares
high sequence homology with another well characterized MT
severing protein P60-katanin in the AAA-region, however, the
other regions of the proteins share little homology [5,6]. Mutations
in spastin are the most common cause for hereditary spastic
paraplegia (HSP), a heterogeneous group of neurodegenerative
disease affecting primarily the long axons of corticospinal tracts in
the spinal cord [7,8,9,10]. Interestingly, Yu and colleagues
reported that depletion of spastin from neurons causes a significant
reduction in the neurite formation, although it had minimal effect
on the axon length [5]. In neurons, spastin has a far greater
capacity to concentrate at the sites of branch formation and
growth cones [5]. It has been shown that several spastin binding
proteins are components of vesicular/membrane trafficking
(atlastin, RTN1, CHMP1B, REEP1 and ZFYVE27) [11,12,13,
14,15]. It is likely that spastin is locally recruited at the branch sites
of the axon by its binding partner(s), where spastin may generate
short MT, which then serves as precursor for neurite formation.
Remarkably, Shirane and Nakayama (2006) have shown that
the spastin interactor ZFYVE27 (synonym protrudin) is also
implicated in neurite formation by promoting directional mem-
brane trafficking [16]. ZFYVE27 protein contains a Rab11
binding domain (RBD11) in its N-terminal region and FYVE
domain in its C-terminal end. It also harbors a FFAT motif, a
coiled-coil domain and spanned by three hydrophobic region (HR)
motifs in the central region of the protein. These structural
domains are hallmarks of a protein which might be implicated in
membrane-cargo trafficking. Rab11 regulates membrane traffic at
the trans-Golgi network–recycling endosome boundary and
recycles them back to the plasma membrane [17,18,19].
Overexpression of ZFYVE27 in PC12 cell lines and primary
hippocampal neurons lead to extensive neurite outgrowth [16].
Likewise, down-regulation of endogenous ZFYVE27 in PC12 cells
by RNA interference results in inhibition of neurite outgrowth
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soma [16]. Overall, these data suggests that ZFYVE27 may play a
vital role in neuronal development/differentiation.
In the database, ZFYVE27 was classified as a novel member of
the FYVE family of protein, as its ,70 residues FYVE domain
preserves all the eight conserved cystine residues, which co-ordinate
the binding of two zinc ions in a cross-braced topology [20,21,22].
The FYVE domain is suggested to be responsible for endosomal
localization and majority of the FYVE finger proteins serve as
regulators of endocytic membrane trafficking [23]. The targeting of
FYVEproteins to the endosomal membraneis greatly influencedby
the bi-/multivalent interactions of FYVE motif with PtdIns3P
(phosphatidylinositol 3-phosphate) lipid moiety present in such
membrane-compartment. The recruitment of FYVE protein to the
endosomalmembraneisenhanced byitsoligomerizationasthisway
multiple FYVE domains strengthen the interaction with PtdIns3P
moiety in the membrane [24]. The most well characterized FYVE
domain containing protein, EEA1 (early endosome antigen 1) has
shown to form a parallel homo-dimer through its coiled-coil motif
interaction [24,25]. The homo-dimerization of EEA1 was shown to
juxtapose two C-terminal FYVE domains, thus allowing simulta-
neous interactions with two PtdIns3P head groups [24]. Another
FYVEprotein,SARAwasshowntointrinsicallyforma stabledimer
and higher order oligomer through interaction with FYVE domain,
which is detrimental for its endosomal localization [26,27].
Moreover, a distinct anti-parallel homo-dimer has been reported
for the FYVE domain of Hrs [28].
Based upon structural resemblance with other FYVE proteins, it
can be postulated that ZFYVE27 might also form an oligomeric
structure to render its function. In the present study, we
demonstrate that ZFYVE27 is a peripheral membrane protein,
which assembles into a homo-dimer/tetramer and the core
interaction between the monomers is mediated primarily through
the third hydrophobic region (HR3) motif of the protein. Moreover,
we show that ZFYVE27
DHR3 causes re-distribution of wild-type
ZFYVE27 into the cytosol and deter its ability to promote
protrusions in non-neuronal cells and neurites in neuronal cells.
Results
ZFYVE27 interacts with itself primarily through its HR3
region
We performed yeast two-hybrid (Y2H) screen on human fetal
brain cDNA using full-length human ZFYVE27 as a bait protein
in an attempt to identify ZFYVE27 interacting proteins. Through
Y2H screen, we identified ZFYVE27 itself as its interacting
partner (Fig. 1B). To verify the interaction of ZFYVE27 with itself
and to delineate the domain of the protein which mediates this
interaction, we generated several deletion constructs of ZFYVE27
for direct-Y2H assay (Fig. 1A). Direct-Y2H assay confirmed the
interaction of full-length ZFYVE27 with itself (Fig. 1C). Further-
more, Y2H assay with generated deletion constructs revealed that
the minimal protein fragment of ZFYVE27
150-250 could interact
with full-length ZFYVE27 (Fig. 1C). The ZFYVE27
150-250
fragment harbors the HR3 (185-207 a.a) of the protein, when
HR3 was deleted in ZFYVE27
1-335, it failed to interact with full-
length ZFYVE27 in the Y2H assay (Fig. 1D). The deletion
construct ZFYVE27
1-184 also showed a weak binding affinity
towards the full-length ZFYVE27 (Fig. 1C).
Interaction of ZFYVE27 monomers in the mammalian
cells
To corroborate the ZFYVE27 self-interaction as observed in
Y2H assay, also in mammalian cells, we performed co-immuno-
precipitation experiments with transient co-transfection of full-
length ZFYVE27 (ZFYVE27
WT) tagged with c-Myc tag together
with ZFYVE27
WT or with various deletion constructs tagged with
E2 (Fig. 2A). Co-expression of E2-ZFYVE27
WT and c-Myc-
ZFYVE27
WT in NIH-3T3 cell line and subsequent immunopre-
cipitation with E2-tag antibody and Western blot detection with c-
Myc antibody revealed that E2-ZFYVE27
WT, indeed, could
interact with c-Myc-ZFYVE27
WT (Fig. 2B). Co-immunoprecipi-
tation experiments with protein extract isolated from cells co-
transfected with c-Myc-ZFYVE27
WT and one of the deletion
construct (E2-ZFYVE27
DN(150-404aa) or E2-ZFYVE27
DC(1-150aa) or
E2-ZFYVE27
DHR3(del 185-207aa)) revealed self-interaction between
the investigated proteins (Fig. 2B). We could confirm the
interaction other way around by immunoprecipitation with c-
Myc antibody and Western blot detection with E2-tag antibody
(Fig. S1, supporting data). Since ZFYVE27 is known to interact
with spastin [13], we analyzed the interaction between truncated
ZFYVE27 and spastin. Co-expression of either E2-ZFYVE27
WT
or E2-ZFYVE27
DHR3 together with GFP-Spastin in NIH-3T3 cell
line and subsequent co-immunoprecipitation revealed that spastin
interact with wild-type as well as truncated ZFYVE27 (Fig. S2,
supporting data).
Furthermore, co-expression of E2-ZFYVE27
WT and c-Myc-
ZFYVE27
WT in NIH-3T3 and HeLa cell lines confirmed the co-
localization of both monomers, especially at the sites of protrusions
(Fig. 3A-H). Similarly, overexpression of E2-ZFYVE27
WT and c-
Myc-ZFYVE27
WT in the NSC34 neuronal cell line revealed that
both monomers co-localize primarily at the neurite outgrowths as
well as in the cell soma (Fig. 3I-L).
ZFYVE27 assembles into a homo-dimer/tetramer
In the immunoblots performed with protein lysates from the
cells overexpressing ZFYVE27
WT, we detected a distinct band,
whose size corresponds to dimeric form of the protein in addition
to the ZFYVE27 monomer (Fig. 4A). To validate the observed
SDS-resistant dimeric form of ZFYVE27, we performed sucrose
gradient centrifugation experiments with detergent solubilized cell
lysates from NIH-3T3 cell line expressing E2-ZFYVE27
WT.
Towards this end, the membranes of the cells were solubilized
with 1% Big-CHAPS and the native protein complex was isolated,
which was then subjected to sucrose gradient centrifugation to
fractionate the protein complex based upon their molecular size.
The fractionated samples were resolved by SDS-PAGE and the
oligomeric ZFYVE27 complex was visualized by immunoblotting
with ZFYVE27 antibody. The immunoblot showed a diffused
pattern with the migration of E2-ZFYVE27
WT with highest
intensity in the fractions 14–18 corresponding to the molecular
weight between ,100–180 kDa indicating that the native
ZFYVE27 complex exist as dimeric and/or tetrameric forms
(Fig. 4B). In the immunoblot, the distinct SDS-resistant dimer also
manifested a similar migration profile as the monomeric form of
ZFYVE27 (Fig. 4B).
The HR3 core interaction region of ZFYVE27 is essential
for neurite extension
Since overexpression of ZFYVE27 induces protrusion/neurite
formation in the cells [present study and [16], we sought to
determine the functional relevance of the oligomeric ZFYVE27 in
this process. Interestingly, overexpression of E2-ZFYVE27
DHR3
failed to promote protrusions in all the analyzed cell types; rather,
we observed accumulation of the ZFYVE27 protein in the cytosol,
most likely either along the endoplasmic reticulum (ER) or
cytoskeleton, leading to swelling of the cell soma (Fig. 5A–C). We
did not observe these morphological changes in control untrans-
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ZFYVE27 Forms Oligomerfected cells, as expected (Fig. 5D–F). When we measured the width
of the cytosol across the nucleus of cell, we detected statistically
significant increase in soma size in ZFYVE27
DHR3 expressing cells
in comparison to ZFYVE27
WT expressing or control cells (Fig. S3,
supporting data). Next, we co-expressed E2-ZFYVE27
DHR3
together with c-Myc-ZFYVE27
WT to assess the effect of mutant
protein on the wild-type ZFYVE27 intracellular distribution and
function. Co-expression of the mutant E2-ZFYVE27
DHR3 protein
with c-Myc-ZFYVE27
WT inhibited the ability of wild-type protein
to promote protrusions in both non-neuronal cell lines (NIH-3T3
and HeLa) (Fig. 5G–N) and neuronal (NSC34) cell line (Fig. 5O–
R). Remarkably, mutant E2-ZFYVE27
DHR3 caused redistribution
of c-Myc-ZFYVE27
WT from the site of protrusions to the cytosol
(Fig. 5I, 5M and 5Q).
Next, we evaluated the ability of ZFYVE27
WT and ZFY-
VE27
DHR3 to promote neurite formation in neuronal cells by
expressing them in primary neuronal culture. Neuronal cells
expressing E2-ZFYVE27
WT showed a neuronal morphology
similar to the control neurons (Fig. 6B). Interestingly, neuronal
cells expressing E2-ZFYVE27
DHR3 revealed swelling of the cell
Figure 1. Yeast two-hybrid (Y2H) screen showing self-interaction of ZFYVE27. (A) Schematic diagram showing the structural domains of
ZFYVE27 and delineation of various deletion constructs of ZFYVE27. ZFYVE27 contains Rab11 binding domain RBD11 (red) at its N-terminus and FYVE
domain (purple) at C-terminus. The three hydrophobic regions (HR) are depicted in green and the overlapping region of HR1 region with the RBD11
motif is highlighted in yellow. The FFAT motif (pink) and the coiled-coil region (blue) mediate interaction with VAP-A protein. The generated deletion
constructs for Y2H analysis are depicted thereof. (B) Activation of GAL4 reporter genes by interaction of ZFYVE27 with the prey clone (ZFYVE27) in
the Y2H screen. A robust growth of yeast strain AH109 was observed on the nutritional selection medium -LTHA (lacking leucine, tryptophan,
histidine and adenine) and also was positive for the a-galactosidase (a-gal) activity. (C) Determination of the core interaction region of ZFYVE27,
which mediate self-interaction by direct-Y2H. The indicated deletion constructs of ZFYVE27 were fused with DNA binding domain of GAL4 and
evaluated for their ability to interact with full-length ZFYVE27 fused to activation domain of GAL4 in Y2H experiments. The interaction between p53
and T-antigen was used as a positive control in the Y2H assay. (D) Evaluation of ZFYVE27-DHR3 (deletion of HR3 in ZFYVE27
1-335 construct)
interaction with full-length ZFYVE27.
doi:10.1371/journal.pone.0029584.g001
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neuronal cell lines (Fig. 5A–C). Further, co-expression of c-Myc-
ZFYVE27
WT and E2-ZFYVE27
WT in primary neurons led to
increased branch sites and enhanced neurite extension (Fig. 6D–
F). In contrast, co-expression of both c-Myc-ZFYVE27
WT and
truncated E2-ZFYVE27
DHR3 in primary neuronal cells caused
impairment of neuritogenesis (Fig. 6G-I).
ZFYVE27 is a peripheral membrane protein
To assess the membrane association properties of ZFYVE27,
we used NSC34 cells expressing ZYFVE27 endogenously.
Western blot analysis with ZFYVE27 antibody on protein
isolated from membrane and soluble cytosol of NSC34 cells
indicated that the monomeric ZFYVE27 localized into the
membrane (Fig. 7). In contrast the SDS-resistant dimeric form of
ZFYVE27 was enriched in the cytosolic fraction (Fig. 7). Next,
the membrane fraction was treated with Triton X-114 to
dissociate the peripheral membrane proteins from the membrane
bilayer. Immunoblot analysis of the resultant aqueous and
detergent fraction proteins after Triton X-114 membrane phase
separation revealed that ZFYVE27 monomer is a peripheral
membrane protein (Fig. 7).
Figure 2. Co-immunoprecipitation assay to validate interaction of ZFYVE27 in mammalian cells. (A) Schematic representation of full-
length and deletion constructs of ZFYVE27 for mammalian expression studies. (B) The full-length ZFYVE27 fused with c-Myc epitope tag was used for
validation of its interaction with E2 tagged ZFYVE27, N-terminus (DC), C-terminus (DN) as well as with ZFYVE27 lacking the third hydrophobic region
(DHR3) in NIH-3T3 cells. The cells were transiently transfected with respective constructs and subsequently co-immunoprecipitation was performed.
The cell lysates were subjected to immunoprecipitation with E2 tag antibody and the resulting immunoprecipitants were analyzed in the
immunoblot with c-Myc tag antibody (Co-IP: E2; WB: c-Myc). A portion of the cell lysates (input) was also subjected to immunoblot with either c-Myc
(WB: c-Myc) or E2 (WB: E2) tag antibodies to verify the protein expression of the indicated constructs. For mock experiments, the cell lysates were
precipitated with non-specific IgG and subsequently analyzed by immunoblotting (as described above).
doi:10.1371/journal.pone.0029584.g002
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to PtdIns3P
In silico analysis of the FYVE domain from ZFYVE27 revealed
that although it has the conserved cysteine residues to co-ordinate
the zinc ion binding, it lacks the conserved FYVE signature motifs;
WXXD, RVC and R(R/K)HHCR (Fig. 8A), which facilitate the
binding of FYVE domain to PtdIns3P specifically. To assess the
PtdIns3P binding properties of ZFVYE27, we performed liposo-
mal assay using PolyPIPosomes. Interestingly, our liposomal assay
clearly showed that PtdIns3P containing PolyPIPosomes could pull
down c-Myc-ZFYVE27
WT (Fig. 8B) and as a positive control; we
could detect the binding of endogenous EEA1 to PolyPIPosomes
(Fig. 8B). To rule out the possibility of indirect binding of
ZFYVE27 to PtdIns3P via some linker proteins, we used
recombinant ZFYVE27 (GST-ZFYVE27
300-404) in the liposomal
assay. The GST-ZFYVE27
300-404 protein also showed binding
specificity for the PtdIns3P (Fig. 8C).
Discussion
ZFYVE27 was initially identified as a spastin binding protein
[13]. Subsequently, Shirane and Nakayama (2006) has shown that
ZFYVE27 (Protrudin) plays a crucial role in membrane trafficking
in cells [16]. When ZFYVE27 was overexpressed in neuronal and
non-neuronal cells, it induced neurites and protrusions, respec-
tively, from the cell soma. ZFYVE27 along with Rab11 was shown
to act as important determinant of the directional membrane
trafficking and this activity is essential for neurite outgrowth in
neuronal cells [16,19]. To gain mechanistic insights into the role of
ZFYVE27 in directional membrane transport during neurite
formation, we attempted to identify proteins which interact with
ZFYVE27 by means of Y2H screen.
Through Y2H assay, we identified ZFYVE27 as its own
interaction partner, suggesting that ZFYVE27 form an oligomer.
We confirmed the interaction of ZFYVE27 with itself by direct-
Y2H assay. Next, to delineate the domain/motif through which
ZFYVE27 self-associate, we generated a series of deletion
constructs of ZFYVE27 and assessed their interaction with full-
length ZFYVE27 by direct-Y2H analysis. By means of these
deletion constructs, we could map the core interaction region to
HR3 (185-207 a.a) motif of ZFYVE27. Next, we also showed that
ZFYVE27 interact with itself in mammalian cells by co-
immunoprecipitation and co-localization studies. The co-immu-
noprecipitation studies indicated that the protein fragments;
ZFYVE27
DN, ZFYVE27
DHR3 and ZFYVE27
DC were also able
to interact with full-length ZFYVE27
WT. These data suggests that
several regions of the ZFYVE27 protein serve as stabilizer for the
oligomeric structure. In particular, the coiled-coil region in the C-
terminus and HR1/HR2 motifs in the N-terminus could serve as
stabilizer for ZFYVE27 oligomer. It was shown that the coiled-coil
region of EEA1 is critical for homo-dimerization [24]. Surpris-
ingly, when assessed by direct-Y2H assay, the deletion of HR3
(ZFYVE27
DHR3) was sufficient to abolish its interaction with
ZFYVE27
WT. The discrepancy between co-immunoprecipitation
Figure 3. Co-localization of ZFYVE27 monomers in various cell lines. (A–C) The c-Myc-ZFYVE27
WT and E2-ZFYVE27
WT constructs were used
to analyze the co-localization between ZFYVE27 monomers. Overexpression of both constructs in NIH-3T3 cell line revealed a pronounced formation
of protrusions from cell soma and showed strong co-localization of ZFYVE27 monomers in the protruded structures. (E–G) A similar protrusions and
co-localization was also observed in HeLa cells. (I–K) Overexpression of ZFYVE27
WT monomers in the NSC34 (a mouse embryonic spinal cord–
neuroblastoma hybrid cell line) resulted in extensive neurite formation with bead-like structures. The ZFYVE27
WT monomers showed strongest co-
localization in the neurite-beads. (D, H, and L) Protrusion assay R Quantification of proportion of the cells, doubly transfected (E2-ZFYVE27
WT and c-
Myc-ZFYVE27
WT) showing protrusions versus showing no protrusions. Scale bars – 50 mm (A–C, E–G and I–K); n, number of cells analyzed. Error bars
indicate the standard deviation (SD) of protrusion assessment by two independent observers.
doi:10.1371/journal.pone.0029584.g003
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detection by these experimental systems. As Y2H assay reveals
direct interaction between two proteins, however, co-immunopre-
cipitation will also detect indirect interaction among proteins in an
oligomeric complex.
To decipher the oligomeric nature of ZFYVE27, we performed
sucrose gradient centrifugation and showed that ZFYVE27
oligomerizes into dimer/tetramer forms. Although, majority of
FYVE proteins form a dimer, they can further form a higher order
quaternary structure as reported for Hrs [29]. Hrs was shown to
form a hexamer and the oligomeric form of Hrs comprises a trimer
of dimers [29]. Also, a quaternary structure of EEA1 has been
postulated, where two dimeric EEA1 juxtapose and elicit its
function as a tetramer [24]. Similarly, ZFYVE27 dimers might
constitute a tetrameric structure.
Notably, we detected a SDS-resistant dimeric form of
ZFYVE27 by immunoblot analysis, both in the fractions of
sucrose gradient centrifugation as well as when conventional SDS-
PAGE analysis was performed. In sucrose gradient centrifugation,
the sedimentation properties of SDS-resistant form of ZFYVE27
was similar to that of SDS soluble ZFYVE27. The observation of
SDS-resistant form is not unique to ZFYVE27 as it was also
reported for EEA1 [25]. Perhaps, a covalent bond formation
between two monomers during homodimerization leads to the
formation of this SDS-resistant FYVE dimeric form.
Majority of FYVE proteins are peripheral membrane proteins
and they are targeted to membrane surface by specific binding to
PtdIns3P, which are located in specific cargo vesicles derived from
endosome [23,30,31,32]. The membrane translocation is further
facilitated by additional interaction of FYVE protein with other
membrane proteins, for example; in case of EEA1, its interaction
with Rab5 significantly increases the avidity of binding of EEA1 to
membrane [31,32,33,34]. In silico prediction of ZFYVE27 protein
structure indicates that it consists of three hydrophobic regions
(HR1-3). A recent study reported that ZFYVE27 interacts with
VAP-A protein and postulated that ZFYVE27 may be an integral
membrane protein [35]. In contrast, our sub-cellular fractionation
and Triton X-114 lipid/aqueous phase separation analysis
revealed that ZFYVE27 is a peripheral membrane protein, which
conforms to the membrane association properties of other FYVE
family proteins, which are also peripheral membrane proteins
[23,30,31,32].
Remarkably, the SDS-resistant dimeric form of ZFYVE27 was
detectable exclusively in the soluble cytosolic fraction. It can be
envisaged that in a monomeric form of ZFYVE27, the three HR
regions are probably masked by its interaction with membrane
(Fig. 9). The homodimerization of ZFYVE27 on the surface of the
membrane might have been facilitated by the hydrophobic-
hydrophobic interaction between the HR regions among the
monomers. In the homodimeric form, the HR regions might
Figure 4. ZFYVE27 assembles into SDS-sensitive and –resistant dimer/tetramer. (A) The protein lysates from NIH-3T3 cells overexpressing
either E2-ZFYV27
WT or c-Myc-ZFYVE27
WT were subjected to immunoblot with ZFYVE27 specific antibody. Asterisks denote the formation of SDS-
resistant dimers corresponding to E2-ZFYV27
WT (, 92 kDa) and c-Myc-ZFYVE27
WT (, 120 kDa). Note: In pCS2-myc vector, six c-Myc epitope tags are
fused in tandem therefore resultant c-Myc-ZFYVE27
WT protein is larger in size (,55 kDa) as compared to E2-ZFYVE27
WT protein (,46 kDa). (B) The
NIH-3T3 cells transiently transfected with E2-ZFYV27
WT were solubilized in 1% Big-CHAPS and size-fractionated by 5-30% sucrose gradient
centrifugation. The resultant fractions were analyzed by immunoblot with ZFYVE27 antibody; asterisks denote the formation of SDS-resistant dimers.
The mobility of molecular weight markers in the sucrose gradient are indicated on the top.
doi:10.1371/journal.pone.0029584.g004
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DHR3 deters the ability of wild-type ZFYVE27 to promote directional membrane trafficking. (A–C)
Overexpression of the mutant E2-ZFYVE27
DHR3 (truncated ZFYVE27) failed to induce protrusions in all the analyzed cell lines (NIH-3T3, HeLa and
NSC34) and caused cytoplasmic swelling with accumulation of protein either along endoplasmic reticulum or cytoskeleton. (D–F) Staining of control
untransfected NIH-3T3, HeLa and NSC34 cells with a-tubulin showed no abnormal morphology. (G–R) Co-expression of both the c-Myc-ZFYVE27
WT
and mutant E2-ZFYVE27
DHR3 in various cell lines (NIH-3T3, HeLa and NSC34) showed the co-localization of both forms of ZFYVE27 in the cytosol.
Notably, majority of cells co-expressing wild-type as well as ZFYVE27
DHR3 failed to produce protrusions but rather caused swelling of the cytosol (I, M,
and Q). Protrusion assay R Quantification of proportion of the cells, doubly transfected (E2-ZFYVE27
DHR3 and c-Myc-ZFYVE27
WT) showing
cytoplasmic swelling (no protrusions) versus cells producing protrusions (J, N and R). Scale bars – 50 mm (A–C, D–F, G–I and K–M), 10 mm (O–Q); n,
number of cells analyzed. Error bars indicate the standard deviation (SD) of protrusion assessment by two independent observers.
doi:10.1371/journal.pone.0029584.g005
ZFYVE27 Forms Oligomer
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from the hydrophilic cytosol, thus, rendering a stable soluble
dimeric ZFYVE27 in the cytoplasm (Fig. 9). The physiological
function of a soluble ZFYVE27 dimer is not yet evident, but its
ability to exist as a soluble form may allow itself to dock to various
vesicular compartments swiftly, which could allow ZFYVE27 to
promote directional membrane trafficking efficiently.
The FYVE proteins are targeted to endosomal membrane due
to their ability to specifically bind to head-group of PtdIns3P lipids,
which are localized in the endosomal vesicles [23]. The conserved
FYVE signature motifs; WXXD, RVC and R(R/K)HHCR are
critical for specific binding to PtdIns3P moiety [26], however in
silico analysis revealed that ZFYVE27 show minimal sequence
conservation at these signature motifs. In vitro liposome binding
assay revealed that ZFYVE27 still retains the ability to bind to
PtdIns3P moiety. Although, the FYVE domain of several proteins
show binding specificity to PtdIns3P in vitro, but when expressed in
cells, many FYVE proteins show a different subcellular localization
than to endosomes [36,37], therefore our finding should be
interpreted with discretion. In this context, it is relevant to
mention that in the neuronal cells, ZFYVE27 localizes in the ER
under basal conditions; however, it translocates to recycling
endosomes (RE) in response to nerve growth factor stimulation
and through RE trafficked to the sites of neurite extension [16].
ZFYVE27 contain a FFAT motif, which could be responsible for
its ER localization [35]. The FFAT motif is present in several
lipid-binding proteins, which are involved in the transport of lipids
between the ER and the Golgi apparatus [38,39]. Additionally, the
ER localization of ZFYVE27 could be aided by its interaction with
VAP-A and Rab11, which are shown to localize to ER [16,35].
Interestingly, the Rab11 is a core component of RE [17,18,22], it
is likely that translocation of ZFYVE27 to RE is facilitated by its
interaction with Rab11.
Overexpression of ZFYVE27 promotes neurite extension from
the cell soma and ZFYVE27 is concentrated in the tip of the
protruding neurite [16]. Surprisingly, overexpression of truncated
ZFYVE27
DHR3 in cells failed to induce protrusions/neurites rather
caused swelling of cell soma and the mutant protein showed
accumulation either along the ER or cytoskeleton. The cytoplasmic
swelling could be due to the inability of ZFYVE27
DHR3 to promote
directional membrane trafficking thus leading to accumulation of
membrane cargoes within the cytosol. To evaluate the effect of
ZFYVE27
DHR3 on the function of olgiomeric ZFYVE27, we co-
expressed it with ZFYVE27WT inboth neuronal and non-neuronal
Figure 6. The truncated ZFYVE27
DHR3 impairs the ability of wild-type ZFYVE27 to promote neurites in primary neuronal cells. (A)
Control primary neurons stained for b-III tubulin, a neuronal marker. Overexpression of E2-ZFYVE27
WT (B) and E2-ZFYVE27
DHR3 (C) in primary neuronal
cells. Arrow in (C) showing the swelling of the cell soma of a neuronal cell expressing E2-ZFYVE27
DHR3.( D–F) Overexpression of both wild-type
ZFYVE27 (c-Myc-ZFYVE27
WT and E2-ZFYVE27
WT) proteins revealed an enhanced neurites formation from the cell soma and showed co-localization of
ZFYVE27 monomers. (G–I) Co-expression of both the c-Myc-ZFYVE27
WT and mutant E2-ZFYVE27
DHR3 in primary neurons showed the co-localization of
both forms of ZFYVE27 mostly in cell soma and the neuron failed to produce normal length axon as well as /dendrites. Scale bars – 20 mm (A–C),
50 mm (D–F), 10 mm (G–I).
doi:10.1371/journal.pone.0029584.g006
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DHR3 exerted a dominant negative effect on
ZFYVE27
WT. The cells co-expressing ZFYVE27
WT and ZFY-
VE27
DHR3 were also unable to produce protrusions and showed
cytoplasmic swelling as observed for cell expressing only ZFY-
VE27
DHR3. Moreover, the ZFYVE27
WT was re-distributed into the
cytosol along with ZFYVE27
DHR3. The co-immunoprecipitation
studies revealed that the truncated ZFYVE27
DHR3 still retains the
ability to interact with ZFYVE27
WT to form oligomer. It was also
able to bind to spastin. Although, a hetero-oligomeric complex of
ZFYVE27
WT/ZFYVE27
DHR3 is non-functional as it could not
promote protrusion/neurite extensions rather caused cytoplasmic
swelling.Overall,ourfindingssuggestthatafunctionallyactive form
of oligomer is essential for ZFYVE27 ability to promote neurite
extensions in neurons and highlights the role of HR3 motif in
directional membrane trafficking.
Interaction of ZFYVE27 with spastin, VAP-A/B and KIF5A
highlights its role in motor neuron disease [13,35,40]. Mutations in
spastin and KIF5A are the primary cause for HSP [7,8,9,10,41]
and mutation in VAP-B causes amyotrophic lateral sclerosis (ALS)
[42,43]. Both diseases share overlapping symptoms and mutation
in spastin has been identified in the ALS patient [44]. It is
interesting to note that overexpression of spastin in neurons causes
a dramatic increase in the neurite extension formation [5]. It is
probable that spastin, through it’s interaction with ZFYVE27
could be recruited to the sites of neurite formations, where spastin
can produce short MT by local severing and facilitate the
promotion of the neurite extension [2,3,4]. Similarly, it was shown
that interaction of ZFYVE27 with VAP-A is essential both for its
localization to ER and for its ability to promote neurite extension
[35]. Taken together, it is evident that ZFYVE27 along with the
interaction partners such as spastin, VAP-A/B, Rab11 and KIF5A
are components of a common cellular process, which may be
essential for neuritogenesis. Dysfunction of this molecular pathway
could be an underlying cause for the pathogenesis of motor neuron
diseases such as HSP and ALS.
Materials and Methods
Yeast-two hybrid (Y2H) screen
We used the Matchmaker Two-Hybrid System kit (BD Clontech)
for identification of putative ZFYVE27 interacting proteins. To
generate the bait construct, the full-length human ZFYVE27 cDNA
(GenBank accession No.: NM_001002262.2) was PCR amplified
from human fetal brain cDNA and cloned into EcoR I and BamH I
restriction sites of pGBKT7 vector (BD Clontech), resulting in a
fusion of GAL4 DNA-binding domain with ZFYVE27. The
pGBKT7-ZFYVE27 construct was transformed into AH109 yeast
strain to test and exclude auto-activation of GAL4 activated
reporter genes, HIS3, ADE, LacZ. The yeast two-hybrid screen was
performed on a human fetal brain cDNA library (constructed in
pGADT7-Rec plasmid) using a Matchmaker pre-transformed kit
(BD Clontech). The matchmaker pre-transformed library in yeast
strain Y187 was mixed and mated together with strain AH109
containing the ZFYVE27 bait construct. After 24 hrs of mating, the
culture was spread on SD/-Leu/-Trp/-His/-Ade plates and the
survivingcolonieswereverified onSD/-Leu/-Trp/-His/-Ade/+X-
a-Gal. The positive clones were cultured and the plasmid DNA was
isolated using QIAprep Spin Miniprep Kit (Qiagen). The cDNA
inserts of these plasmid clones were PCR amplified and sequenced.
Identities of cDNA clones were determined by BLAST analysis
(http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Direct Y2H assay
For mapping the core self-interaction region of ZFYVE27,
several deletion bait (pGBKT7) and prey (pGADT7) constructs of
ZFYVE27 were generated. Following fragments of ZFYVE27 were
used for deletion constructs (as outlined in Fig. 1A); 1–335 a.a
(amino acids) [corresponding nucleotides (nt) 201–1205 of NM_
001002262.2], 110–335 a.a (nt 528–1205), 150–250 a.a (nt 648–
939), 174–218 a.a (nt 720–854), 1–184 a.a (nt 201–752) and 208–
404 a.a (nt 822–1412). For direct Y2H assay, the ZFYVE27 bait
and prey constructs were co-transformed into AH109 strain by
lithium acetate method [45]. The co-transformants were first
selected on SD/-Leu/-Trp plates and later tested for the reporter
gene expression on SD/-Leu/-Trp/-His/-Ade and X-a-Gal plates.
Construction of mammalian expression plasmids
The pGBKT7-ZFYVE27 plasmid DNA was used as a template
for the PCR amplification and cloning of ZFYVE27 into BamH I
and Kpn I restriction sites of pQM-N-Tag A (Abcam) to generate
E2-ZFYVE27
WT construct. To generate c-Myc-ZFYVE27
WT
construct, ZFYVE27 ORF was cloned into EcoR I site of pCS2-
myc expression vector [46]. [Note: In pCS2-myc vector, six c-Myc
epitope tags are fused in tandem therefore resultant c-Myc-
ZFYVE27 protein is larger in size as compared to E2-ZFYVE27
protein]. The E2-ZFYVE27 was used as a template for PCR
amplification of a plasmid lacking HR3 (nt 750–822 of
NM_001002262.2) using a modified QuickChange based PCR
reaction (Stratagene) with primers complementary to the both 59
and 39 flanking regions of HR3 and generated the E2-
ZFYVE27
DHR3 construct. For the generation of E2-ZFY-
VE27
DC1-150 and E2-ZFYVE27
DN150-404 constructs, these frag-
ments were PCR amplified and cloned into BamH I/Kpn I
restriction sites of pQM-N-Tag A vector. Spastin-GFP construct
was a kind gift from Dr. Elena I. Rugarli [7].
Cell culture, immunofluorescence and immuno-
precipitation experiments
The NIH-3T3 (ATCC Nr.: CRL-1658) and HeLa (ATCC Nr.:
CCL-2) cells were cultured and maintained as previously described
Figure 7. ZFYVE27 is a peripheral membrane protein. Sub-
cellular fractionation was performed with NSC34 cell extract. The
cytosolic fraction (S-100) and the membrane fraction (P-100) were
analyzed by immunoblot with ZFYVE27 antibody. Asterisks denote the
non-specific band. The monomeric ZFYVE27 (mo-ZFYVE27) and SDS-
resistant dimeric ZFYVE27 (di-ZFYVE27) are indicated. The membrane
fraction (P-100) was subjected to Triton X-114 phase separation and
equal volumes of aqueous phase (peripheral) and detergent phase
(integral) fractions were analyzed by immunoblotting. The blot was
stripped and re-probed with COX4 antibody, a marker for the integral
membrane protein.
doi:10.1371/journal.pone.0029584.g007
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hybrid cell line with motor neuronal properties [47] was a kind gift
from Dr J. Weishaupt (University of Goettingen, Germany). The
cells were cultured and maintained in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum
(FBS) and 1% penicillin/streptomycin/glutamine solution as
previously reported [46]. The generation of mouse primary
neuronal cells and culture conditions were described elsewhere
[48]. For all the cell lines, transfection was done using
Lipofectamine2000 reagent (Invitrogen) according to the manu-
facturer’s instructions. Immunofluorescence and immunoprecipi-
tation experiments were essentially performed as previously
described [12,46]. ImageJ program (http://rsbweb.nih.gov/ij/
index.html) was used to measure the width of the cell body across
the nucleus and the data were analyzed by Student’s t-test
application of GraphPad Prism4.0 (GraphPad Software).
Sucrose density gradient experiments
For sucrose density gradient centrifugation, the NIH-3T3 cells
overexpressing E2-ZFYVE27
WT were washed two times (10 min
each) with PBS and incubated with HKME buffer (25 mM HEPES,
pH 7.8, 150 mM potassium acetate, 2.5 mM magnesium acetate,
1 mM EDTA and protease inhibitor cocktail) containing 1% Big-
CHAPS for 15 min. The cells were then harvested by scrapping
them from plastic surface of the culture flask and incubated for
30 min on ice with mild vortex for cell lysis. The cell debris from the
protein lysate was removed by centrifugation at 10,000 g for 10 min
at 4uC and 200 ml of the resultant supernatant was applied on 5–
30% sucrose gradients and centrifuged at 135,000 g for 4 hrs at
25uC on a Beckman coulter ultracentrifuge with TLS55 rotor.
Approximately thirty gradient fractions of 50 ml( e a c h )w e r e
collected from top to bottom and were analyzed by SDS-PAGE
followed by immunoblotting with ZFYVE27 antibody (polyclonal
antibody raised against the mouseZFYVE27
213-344 protein in rabbit
as host). Molecular masses were calculated from the sedimentation
of standard molecular weight markers: albumin, bovine serum
(,66 kDa), alcohol dehydrogenase, yeast (,150 kDa) and apofer-
ritin, horse spleen (,450 kDa) purchased from Sigma-Aldrich.
Subcellular fractionation and Triton X-114 membrane
phase separation
Subcellular fractionation was performed with NSC34 cells. The
trypsinized cells were suspended in a buffer containing 20 mM
HEPES pH 7.8, 150 mM NaCl and protease inhibitor cocktail
Figure 8. ZFYVE27 a novel member of FYVE family, which show binding affinity towards PtdIns3P. (A) Alignment of the FYVE domain of
ZFYVE27 (ZFY27) with other FYVE family proteins; EEA1, ZFYVE9 (ZFYV9), HGS/HRS and yeast FAB1, PEP7, VPS27. The red boxes are highlighting the
conserved WXXD motif (1), R(R/K)HHCR motif (2) and RVC motif (3). The conserved cysteine residues which co-ordinates the zinc ion binding were
marked with asterisks. (B) The liposomal binding assay shows specific binding of c-Myc-ZFYVE27
WT to the PolyPIPosomes consisting of PtdIns3P.A sa
positive control, we also detected the binding of endogenous EEA1 to the PolyPIPosomes. (C) The recombinant GST-ZFYVE27
300-404 protein also
showed binding affinity to PtdIns3P. As a negative control, GST (alone) protein was used in the liposomal binding assay.
doi:10.1371/journal.pone.0029584.g008
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times). The homogenate was centrifuged at 4uC for 5 min at
3,000 g to obtain post nuclear supernatant and the resultant
supernatant was then centrifuged at 100,000 g for 60 min. The
supernatant containing the cytosolic fraction (S-100) was separated
and the pellet containing membrane fraction (P-100) was
resuspended with the buffer to the original volume. Each
subcellular fraction (20 ml) was then resolved in SDS-PAGE and
immunoblotted with ZFYVE27 antibody.
The Triton X-114 phase separation was essentially performed
as described previously [49]. Briefly, the membrane fraction
(prepared as above) was mixed with pre-condensed Triton X-114
to a final concentration of 2% and incubated on ice for 30 min
with occasional mixing. The detergent soluble fraction obtained
after centrifugation at 16,000 g for 15 min at 4uC was subjected to
aqueous and detergent phase separation at 37uC (cloudy point
temperature) for 5 min and centrifuged at room temperature for
5 min at 16,000 g. The detergent phase containing integral
proteins and aqueous phase containing peripheral proteins were
separated and subjected to one more round of separation for
enrichment. Finally, detergent and aqueous phases were pooled
separately and the proteins were precipitated using standard
acetone precipitation method [50]. After acetone precipitation, the
protein pellets were resuspended and denatured in SDS-PAGE
loading buffer and 20 ml of each fraction was analyzed by SDS-
PAGE and immunoblotting.
Liposomal Binding Assay
The liposomal binding assay was carried out by using pre-made
PolyPIPosomes consisting of PtdIns3P moiety (Echelon Bioscienc-
es) as the substrate for ZFYVE27 protein. The full-length
ZFYVE27 protein was produced by transient transfection of
HeLa cells with c-Myc-ZFYVE27
WT construct. Also, a recombi-
nant GST-ZFYVE27
300-404 was produced in E. coli BL21 (DE3)
strain and purified by glutathione sepharose-column (Sigma). The
protein of interest (100 mg of HeLa cell extracts or 10 mgo f
purified protein) was diluted to 200 ml with binding buffer (50 mM
Tris-HCl pH 7.6, 150 mM NaCl and 0.05% Nonidet P40), mixed
with 10 ml of PolyPIPosomes and incubated overnight at 4uC. The
next day, samples were centrifuged at 20,000 g for 1 hr at 4uCt o
precipitate the protein-liposome complex. The pellet containing
protein-liposome complex was analyzed by Western blot with anti-
ZFYVE27, EEA1 and GST antibodies.
Supporting Information
Figure S1 Validation of interaction of E2- ZFYVE27
(various domains) with c-Myc-ZFYVE27 by co-immuno-
precipitation assay in mammalian cells. The NIH-3T3 cells
were co-transfected with full-length ZFYVE27 fused with c-Myc
epitope tag and E2tagged ZFYVE27 (full-length) or N-terminus (DC)
or C-terminus (DN) or ZFYVE27 lacking the core interaction region
(DHR3). The cell lysates were subjected to immunoprecipitation with
c-Myc tag antibody and the resulting immunoprecipitants were
analyzed in the immunoblot with E2 tag antibody (Co-IP: c-Myc;
WB: E2). A portion of the cell lysates (input) was also subjected to
immunoblot with E2 (WB: E2) tag antibodies to verify the protein
expression of the indicated constructs. For mock experiments, the cell
lysates were precipitated with non-specific IgG and subsequently
analyzed by immunoblotting (as described above).
(TIF)
Figure S2 Interaction of spastin with wild-type and
truncated ZFYVE27. The NIH-3T3 cells were co-transfected
with GFP-Spastin together with either E2-ZFYVE27
WT or E2-
ZFYVE27
DHR3. Subsequently, the protein extracts were subjected
to immunoprecipitation (IP) with E2-tag specific antibody or
rabbit IgG (mock) and the resulting immunoprecipitants were
analyzed by Western blot (WB) with GFP antibody. A portion of
the cell lysates (input) was subjected to WB with both E2 and GFP
antibodies to confirm the expression of indicated constructs.
(TIF)
Figure S3 The mutant ZFYVE27
DHR3 expression causes
swelling of the cell soma. Bar graph showing the average
width of the cell body measured across the nucleus using ImageJ
program in untransfected (control) or transfected with either
ZFYVE27
WT or ZFYVE27
DHR3 constructs in NIH-3T3 (A),
HeLa (B) and NSC34 (C) cells. Parenthesis indicates the number
of cells (n) used for the analysis. Statistical significance is analyzed
by Student’s t-test (***P,0.0001).
(TIF)
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